MI Sign Up for eTOC Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 


Receive this page by email each issue: [Sign up for eTOCs]

Cover Image
Other Issues:
Contents: August 1 2005, Volume 5, Issue 4   [Index by Author] 
       Viewpoints
       Reviews
       Open Channels
       Reflections
       Beyond the Bench
       Net Results
       Outliers
Find articles in this issue containing these words:
[Search ALL Issues]


To see an article, click its [Full Text] link. To review many summaries, check the boxes to the left of the titles you want, and click the 'Get All Checked Summary(s)' button. To see one summary at a time, click its [Summary] link.

Viewpoints:

Dispatches from the Frontlines of Research - edited by John W. Nelson

Ajay Goel, Christoph Gasche, and C. Richard Boland
Chemoprevention Goes Gourmet: Different Flavors of NO-Aspirin
Mol. Interv. 2005 5: 207-210. [Summary] [Full Text] [PDF]  

Marko Pesu, John O’Shea, Lothar Hennighausen, and Olli Silvennoinen
Identification of an Acquired Mutation in Jak2 Provides Molecular Insights into the Pathogenesis of Myeloproliferative Disorders
Mol. Interv. 2005 5: 211-215. [Summary] [Full Text] [PDF]  

R E V I E W S:

Alessandro Vitale and Emanuela Pedrazzini
Recombinant Pharmaceuticals from Plants: The Plant Endomembrane System as Bioreactor
Mol. Interv. 2005 5: 216-225. [Summary] [Full Text] [PDF]  

A wide variety of crop plants have been cultivated over the millennia with the sole, human-driven objective of maximizing nutrient protein production. The plant cell endomembrane system has evolved to traffic proteins, according to many of the same mechanisms common to mammalian cells, and to accumulate them, by means unknown to mammalian cells, for storage. Today, scientists are turning to the plant cell endomembrane system as a potential source for non-nutrient (pharmaceutical) recombinant proteins. Beyond the exciting prospect of harvesting therapeutic human proteins from plants, the secretory mechanisms in plants offer a fascinating opportunity for understanding a fundamental cellular function that is, in varying forms, ubiquitous.

Anthony P. Williams, Andrew R. Bateman, and Salim I. Khakoo
HANGING IN THE BALANCE: KIR and Their Role in Disease
Mol. Interv. 2005 5: 226-240. [Summary] [Full Text] [PDF]  

How is it that our immune cells know not to attack our own cells? In the case of natural killer (NK) cells, it’s a matter of "examining" the cells they encounter for major histocompatibility complex (MHC) class I antigens. The presence of these antigens on a cell apposed to an NK cell indicates "self," and instructs the NK cell not to attack. Great efforts are being undertaken to identify small molecules that might bolster the immune response in immune-compromised patients, and such research includes investigations into the relevant immunogenetics. Indeed, an individual’s repertoire of MHC class I proteins and killer immunoglobulin-like receptors (KIR) on NK and other immune cells not only underlies responses to infection and the occurrence of autoimmune disease, but also can determine the outcome of malignant disease.

Janice M. Burke and Leonard M. Hjelmeland
MOSAICISM OF THE RETINAL PIGMENT EPITHELIUM: seeing the small picture
Mol. Interv. 2005 5: 241-249. [Summary] [Full Text] [PDF]  

In vivo, ex vivo, or in vitro, the cells that populate a given tissue are not necessarily uniform, neither in terms of cell structure nor pharmacological responsiveness. Much of this cell-cell variability is taken for granted, and yet the inconsistency of tissue response to any of a number of pharmacological agents is often encountered in the literature. Could tissue heterogeneity be responsible? The retinal pigment epithelium is a single tissue that consists of a mosaic of distinctive cells and that may serve as a model for a variety of tissue types. This mosaicism can be characterized at the levels of gene and protein expression, as well as in terms of subcellular structures and resistance to environmental insults.

D E P A R T M E N T S:

Open Channels:

Letters from Our Readers

W. Ross Tracey and Wolfgang Sadée
Open Channels
Mol. Interv. 2005 5: 200. [Full Text] [PDF]  

Reflections:

Science in the cultural context

Stanley Scheindlin
A CENTURY of ULCER MEDICINES
Mol. Interv. 2005 5: 201-206. [Full Text] [PDF]  

Beyond the Bench:

Representations of pharmacology and science in the media

Christie Carrico
Pharmacognostic Gold Spells
Mol. Interv. 2005 5: 250. [Full Text] [PDF]  

Net Results:

Sites of interest on the World Wide Web

Sites of interest on the World Wide Web—edited by Rick Neubig and David Roman
Mol. Interv. 2005 5: 251. [Full Text] [PDF]  

Outliers:

Cartoon


Mol. Interv. 2005 5: 256. [Full Text] [PDF]  

To see an article, click its [Full Text] link. To review many summaries, check the boxes to the left of the titles you want, and click the 'Get All Checked Summary(s)' button. To see one summary at a time, click its [Summary] link.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.